Aparna Wagle Shukla

A Phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of VIM0423 in individuals with isolated dystonia.

An observational study of individuals with isolated dystonia

Drug Development for Dystonia

Progressive resistance exercise and dystonia pathophysiology.

The Essential Tremor Rating Assessment Scale Patient-Reported Outcome (TETRAS ADL PRO) Validation Study

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Range Finding Clinical Trial to Evaluate the Tolerability, Safety, and Efficacy of PRAX-944 in the Treatment of Adults with Essential Tremor

CTOA - Shukla CT salary

STOP-TIC Study: F014647 Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT#

STOP-TIC Study: Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT

Dystonia Coalition Projects-3

Cerebellar and Basal Ganglia Markers Underlie Neuromotor Impairments in Adults with Autism Spectrum Disorder (ASD)

Synergism of botulinum toxin and repetitive transcranial magnetic stimulation for motor and non-motor symptoms of cervical dystonia

A PHASE 2, DOUBLE-BLIND, PLACEBO CONTROLLED, RANDOMIZED STUDY EVALUATING THE EFFICACY, SAFETY, AND TOLERABILITY OF SAGE-324 IN THE TREATMENT OF INDIVIDUALS WITH ESSENTIAL TREMOR

Physiological effects of Botulinum Toxin therapy in Primary Cervical Dystonia

Functional Brain networks in essential Tremor and dystonic tremor

A PHASE 2,OPEN-LABEL,DOSE-ESCALATING STUDY TO EVALUATE THE SAFETY & PRELIMINARY EFFICACY OF RTT150 FOR INJECTION IN ...

GÇ£rTMS therapy for primary orthostatic tremor: A novel treatment approachGÇ¥

Combined therapy with rTMS and botulinum toxin in primary cervical dystonia

“A 12 Month, Dose-Level Blinded Study Investigating the Safety and Efficacy of CVT 301 (Levodopa Inhalation Powder) in Parkinson’s Disease Patients With Motor Response Fluctuations (OFF Phenomena)

Combined effects of rTMS and botulinum toxin in benign essential blepharospasm: A novel approach

UFF Companion Project to ABF 2014 Clinical Research Training Fellowship in Neurotoxins

A PHASE IIIb, MULTICENTRE, RANDOMISED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF DYSPORT USING 2 mL DILUTION IN ADULTS WITH CERVICAL DYSTONIA

A PHASE IIIb, prospective, MULTICENTRE, open-label EXTENSION STUDY TO ASSESS LONG TERM SAFETY AND EFFECTIVENESS OF DYSPORT

Magnetic Stimulation for the Treatment of Motor and Mood Symptoms of Parkinson’s Disease: A Four-Center, Sham-Controlled, Parallel Group Study-Cost Share